Abstract:Simple Summary Squamous cell carcinoma (SCC) is the most prevalent type of human cancer worldwide and represents the majority of head and neck tumors. As SCC from aerodigestive or genitourinary tracts share not only common etiology and histological features but also molecular patterns, the major objectives of this study were the establishment of a pan-SCC-related prognostic gene signature by an integrative analysis of multi-omics data and the elucidation of underlying oncogenic pathway activities as potential vulnerabilities for a more efficient and less toxic therapy. Our approach delivers a reliable molecular classifier to identify HNSCC and other SCC patients at higher risk for treatment failure with tumors characterized by a more prominent MAPK activity, who might benefit from a targeted treatment with MEK inhibitors. Squamous cell carcinoma (SCC) is the most prevalent histological type of human cancer, including head and neck squamous cell carcinoma (HNSCC). However, reliable prognostic gene signatures for SCC and underlying genetic and/or epigenetic principles are still unclear. We identified 37 prognostic candidate genes by best cutoff computation based on survival in a pan-SCC cohort (n = 1334) of The Cancer Genome Atlas (TCGA), whose expression stratified not only the pan-SCC cohort but also independent HNSCC validation cohorts into three distinct prognostic subgroups. The most relevant prognostic genes were prioritized by a Least Absolute Shrinkage and Selection Operator Cox regression model and were used to identify subgroups with high or low risks for unfavorable survival. An integrative analysis of multi-omics data identified FN1, SEMA3A, CDH2, FBN1, COL5A1, and ADAM12 as key nodes in a regulatory network related to the prognostic phenotype. An in-silico drug screen predicted two MEK inhibitors (Trametinib and Selumetinib) as effective compounds for high-risk SCC based on the Cancer Cell Line Encyclopedia, which is supported by a higher p-MEK1/2 immunohistochemical staining of high-risk HNSCC. In conclusion, our data identified a molecular classifier for high-risk HNSCC as well as other SCC patients, who might benefit from treatment with MEK inhibitors.

KDM5B Overexpression Predicts a Poor Prognosis in Patients with Squamous Cell Carcinoma of the Head and Neck

KDM5B promotes metastasis and epithelial–mesenchymal transition via Wnt/β‐catenin pathway in squamous cell carcinoma of the head and neck

The Prognostic Role of Eg5 Expression in Laryngeal Squamous Cell Carcinoma.

Kdm4a As A Prognostic Marker Of Oral Squamous Cell Carcinoma: Evidence From Tissue Microarray Studies In A Multicenter Cohort

Elevated Expression of Hmgb1 in Squamous-Cell Carcinoma of the Head and Neck and Its Clinical Significance

Prognostic Significance of Dickkopf-1 in Head and Neck Squamous Cell Carcinoma.

Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1

Elevated DKK1 Expression is an Independent Unfavorable Prognostic Indicator of Survival in Head and Neck Squamous Cell Carcinoma

CDK5 and epithelial-mesenchymal transition related proteins are abnormally expressed in head and neck squamous cell carcinoma

Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity

Expression of Kif5b Protein is Significantly Associated with the Progression, Recurrence and Prognosis of Oral Squamous Cell Carcinoma

Overexpression of WD Repeat Domain 5 Associates with Aggressive Clinicopathological Features and Unfavorable Prognosis in Head Neck Squamous Cell Carcinoma.

Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer

Clinicopathological value of hematopoietic cell kinase overexpression in laryngeal squamous cell carcinoma tissues

Comprehensive Analyses of Prognostic Biomarkers and Immune Infiltrates among Histone Lysine Demethylases (kdms) in Hepatocellular Carcinoma

A Comprehensive Evaluation of Prognostic Value and Immune Infiltration of KDM1 Family in Hepatocellular Carcinoma

DNA Methylation-Mediated Klotho Silencing is an Independent Prognostic Biomarker of Head and Neck Squamous Carcinoma

High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.

Identification of the upstream regulators of KDM5B in gastric cancer

Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma

An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker